Over 300 Colorado Auctions End Tomorrow 05/12 - Bid Now
Over 150 Total Lots Up For Auction at Two Locations - PA 05/15, NY 05/20

Mevion installs proton pencil beam scanning technology at MedStar Georgetown University Hospital

Press releases may be edited for formatting or style | April 04, 2017 Rad Oncology Proton Therapy

About Mevion Medical Systems®

Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with offices in the Netherlands, Japan and China. For more information, please visit www.mevion.com.

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

About the MEVION S250 Series™

The MEVION S250 Series is elegantly designed to deliver high-powered, efficient proton therapy treatments. Built upon the world’s only gantry-mounted proton accelerator and benefitting from Mevion’s patented direct beam technology, the MEVION S250 Series delivers on the therapeutic promise of proton therapy while enhancing beam quality, stability and uptime. The result is a high-quality treatment with reduced system complexity, higher reliability and throughput, and lower capital and operating costs—making the MEVION S250 Series a compelling, financially viable solution for all cancer centers. The MEVION S250 Series includes:

MEVION S250 Proton Therapy System®, offering highly stable, next-generation volumetric delivery capabilities
MEVION S250i Proton Therapy System™ with HYPERSCAN™ and Adaptive Aperture™, overcoming pencil beam scanning uncertainties by delivering robust IMPT treatment at hyper-speed
MEVION S250mx™, making proton therapy fully scalable, with two, three and four room designs that are inherently redundant and support 100% facility uptime
The MEVION S250i Proton Therapy System with HYPERSCAN and Adaptive Aperture has not been cleared by the USFDA for clinical use.

Back to HCB News

You Must Be Logged In To Post A Comment